High-flow hydrogen inhalation might suppresses the immune function of middle-aged participants: a self-controlled study.
Ontology highlight
ABSTRACT: Hydrogen inhalation therapy has been proven to be safe and effective in disease treatment in multiple clinical reports, but the gas flow rates used in different studies vary greatly. Since there is no upper limit for the safe concentration of hydrogen, this study tested the effects of high-flow (not high concentration) hydrogen inhalation on immune function. From October 2019 to January 2020, 20 adult participants (31-60 years old) were enrolled in a self-controlled study to check the immune function in peripheral blood lymphocyte subsets before and after a 2-week hydrogen inhalation protocol. The participants inhaled hydrogen for 2 or 4 hours each day. After 2 weeks of hydrogen inhalation, statistically significant changes were observed in follicular helper T cells, helper and cytotoxic T
SUBMITTER: Chen JB
PROVIDER: S-EPMC8103974 | biostudies-literature | 2021 Jan-Mar
REPOSITORIES: biostudies-literature
ACCESS DATA